Efficacy of carvedolol alone and in combination with amlodipine in a multicenter uncontrolled titration study in patients with hypertension and hypercholesterolemia
https://doi.org/10.18705/1607-419X-2007-13-1-76-80
Abstract
In a multicenter uncontrolled titration study efficacy of carvedilol alone and in combination with amlodipine was studies in patients with hypertension and hypercholesterolemia. The study showed high efficacy of carvedilol as a monotherapy and combined with amlodipine in correction of hypertension and positive changes in lipid profile.
About the Authors
Yu. V. Sviryaev
Almazov Federal Center of Heart, Blood an Endocrinology
Russian Federation
Russian Federation
N. E. Zvartau
Almazov Federal Center of Heart, Blood an Endocrinology
Russian Federation
Russian Federation
O. P. Rotari
Almazov Federal Center of Heart, Blood an Endocrinology
Russian Federation
Russian Federation
V. V. Dorofeikov
Almazov Federal Center of Heart, Blood an Endocrinology
Russian Federation
Russian Federation
A. O. Konrady
Almazov Federal Center of Heart, Blood an Endocrinology
Russian Federation
Russian Federation
References
1. Dargie H.J. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomized trial// Lancet 2001; 357:1385-1390.
2.
3. Krum H. et al. Effects of initiating carvedilol in patients with severe chronic heart failure: results from the COPERNICUS Study. JAMA. 2003;289:712-8.
4.
5. Packer M., Colucci W.S., Sackner-Bernstein J.O. et al. Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure. The PRECISE Trial. Prospective Randomized Evaluation of Carvedilol on Symptoms and Exercise// Circulation. 1996;94:2793-9.
6.
7. Stienen U. et al. The Once-Daily Dose Regimen of Carvedilol: a Meta-analysis Approach//Journal of Cardiovascular Pharmacology 1992,19 (Suppl.l):128-133.5.
8.
9. Giugliano D.,Acampora R., Marfella R. et al. Metabolic and cardiovascular effects of carvedilol and atenolol in non-insulin-dependent diabetes mellitus and hypertension. A randomized, controlled trial// Ann Intern Med. 1997;126:955-959.6.
10.
11. Sica D. Current concepts of pharmacotherapy in hypertension. Carvedilol: new considerations for its use in the diabetic patient with hypertension// J Clin Hypertens (Greenwich). 2005;7:59-64.
12.
13. Bakris G.L., Fonseca V., Katholi R.R. et al. Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial. JAMA. 2004;292:2227-2236.
14.
15. Ma X.L., Lopez B.L., Liu G.L. et al. Hypercholesterolemia impairs a detoxification mechanism against peroxynitrite and renders the vascular tissue more susceptible to oxidative injury// Circ Res. 1997;80:894-901.
16.
17. Hauf-Zachariou U., Widmann L., Zulsdorf B. A double-blind comparison of the effects of carvedilol and captopril on serum lipid concentrations in patients with mild to moderate essential hypertension and dyslipidaemia.
18.
19. Uzunlulu M., Oguz A., Yorulmaz E. The effect of carvedilol on metabolic parameters in patients with metabolic syndrome. Int Heart J. 2006;47:421-430.
20.
Review
For citations:
Sviryaev Yu.V., Zvartau N.E., Rotari O.P., Dorofeikov V.V., Konrady A.O. Efficacy of carvedolol alone and in combination with amlodipine in a multicenter uncontrolled titration study in patients with hypertension and hypercholesterolemia. "Arterial’naya Gipertenziya" ("Arterial Hypertension"). 2007;13(1):76-80. (In Russ.) https://doi.org/10.18705/1607-419X-2007-13-1-76-80
Views:
2308
Email this article 